Magnolia Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Magnolia Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$678K	Sell	3,565 -23	-0.6%	-$3.95K	0.12%	186
2026 Q1	$606K	Hold	3,588	–	–	0.12%	186
2025 Q4	$606K	Buy	+3,588	New	+$583K	0.13%	157
2025 Q3	–	Sell	-3,725	Closed	-$471K	–	240
2025 Q2	$471K	Hold	3,725	–	–	0.12%	162
2025 Q1	$476K	Hold	3,725	–	–	0.13%	156
2024 Q4	$492K	Buy	3,725 +478	+15%	+$67.2K	0.13%	159
2024 Q3	$473K	Buy	+3,247	New	+$470K	0.24%	97

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Magnolia Capital Advisors's IBB Position: Q2 2026 in Review

Magnolia Capital Advisors reduced its iShares Biotechnology ETF (IBB) stake by 0.64% in Q2 2026, selling an estimated $3.95K and leaving 3,565 shares worth $678K. The position accounts for 0.12% of the portfolio, ranked #186.

Magnolia Capital Advisors first reported a position in IBB in Q3 2024 and has held it in 7 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Magnolia Capital Advisors held 3,565 shares of iShares Biotechnology ETF worth $678K as of Q2 2026.
Magnolia Capital Advisors sold 23 iShares Biotechnology ETF shares in Q2 2026, an estimated $3.95K.
iShares Biotechnology ETF made up 0.12% of Magnolia Capital Advisors's portfolio in Q2 2026, its #186 holding.
Magnolia Capital Advisors first reported a position in iShares Biotechnology ETF in Q3 2024 and has held it in 7 quarters since.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Magnolia Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.